Thank you for downloading the case study: "Resolving a CAS Registry Number® Discrepancy for a Customer in Brazil"
The case study has been sent to the email address you provided. If you did not receive it, you can download it directly by clicking the button below.
For more information, please visit CAS SciFinder Discovery Platform™.
Latest from CAS Insights™
Drug Discovery
How AI-driven analysis can accelerate drug discovery
Spiro[2.3]hexanes are an example of promising yet challenging scaffold structures for new drug compounds. By using AI-powered predictive analytics with CAS BioFinder, researchers more efficiently identified candidates for validation.
P&D digital
Five Markers of AI Readiness in R&D
AI-powered solutions hold so much potential for faster scientific innovation, but there are key milestones organizations must achieve before they can move beyond the pilot phase. These five markers are the cornerstones of AI readiness.
.avif)
Emerging Science
Point-of-care testing: faster diagnosis, easier access to care
Point-of-care testing goes beyond pandemic-era viral infection tests to bring faster diagnostics for infectious diseases, chronic conditions, cancer, and more.